A Cell-Based Option for Seasonal Influenza Prevention in Persons 6 Months & Older

Host: Charles Turck, PharmD, BCPS, BCCCP <br> Guest: Donald Middleton, MD <br> <p>Influenza causes considerable morbidity and mortality in children. In fact, the CDC estimates that from the 2010-2011 season to the 2019-2020 season, seasonal flu-related hospitalizations among children younger than 5 years old have ranged from 7,000 to as high as 26,000 every year.¹ This is a sobering reminder of the pivotal role vaccination plays in preventing influenza disease, and now, recent safety and immunogenicity data has led to the expanded age indication for the cell-based vaccine FLUCELVAX QUADRIVALENT. Explore that data and what this approval means for patients 6 months of age and older with Drs. Charles Turck and Donald Middleton.</p> <ol> <li>Centers for Disease Control and Prevention. Flu and young children. <a href="https://www.cdc.gov/flu/highrisk/children.htm">https://www.cdc.gov/flu/highrisk/children.htm</a>. Accessed December 22, 2021</li> </ol> <p style="text-align: right;"><span>USA-QIVc-21-0169 December 2021</span></p>